A postmarketing safety programme for generic ticlopidine is being considered by the US FDA

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 1999年 / 753卷 / 1期

关键词：

Public Health; Neutropenia; Thrombocytopenia; Monitoring Programme; Purpura;

D O I：

10.2165/00128415-199907530-00001

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] US FDA enhancing postmarketing drug safety surveillance
[J]. Reactions Weekly, 2019, 1780 (1) : 3 - 3
[2] US FDA Enhancing Postmarketing Drug Safety Surveillance
不详
[J]. PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
[3] The US FDA has requested proposals for an active postmarketing surveillance hospital pilot programme
[J]. Reactions Weekly, 1999, 753 (1) : 2 - 2
[4] US FDA posts report on postmarketing surveillance
[J]. Reactions Weekly, 2019, 1766 (1) : 3 - 3
[5] TOBACCO REGULATION BEING CONSIDERED BY FDA
MCCARTHY, M
[J]. LANCET, 1994, 343 (8898): : 664 - 664
[6] US FDA, EMEA look to harmonise postmarketing surveillance
[J]. Reactions Weekly, 2007, 1152 (1) : 2 - 2
[7] US FDA addresses postmarketing drug surveillance concerns
[J]. Reactions Weekly, 2004, 1030 (1) : 3 - 3
[8] FDA finalises guidance on its postmarketing safety surveillance
[J]. Reactions Weekly, 2024, 1995 (1) : 2 - 2
[9] US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information
Ridge, Sarah
Guinn, Daphne
Fletcher, Elimika Pfuma
Zineh, Issam
Madabushi, Rajanikanth
Ramamoorthy, Anuradha
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (06): : 695 - 703
[10] The US FDA is to review postmarketing reports of serious bleeding associated with dabigatran etexilate
[J]. Reactions Weekly, 2011, 1382 (1) : 5 - 5

← 1 2 3 4 5 →